Werewolf Therapeutics Stock Forecast
NASDAQ: HOWLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 0.96 -2.00%
HOWL analyst consensus
Consensus
none
Avg. price target
$7.00+614.58%
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
The average 12-month price target is $7.00, with a high estimate of $10.00 and a low estimate of $4.00. The average target implies upside of 614.6% from the current price of $0.9796. The spread between the highest and lowest targets is 150.0%, a wide range that reflects significant disagreement among analysts.
Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for HOWL.
Summary generated from market data by MetaCap's automated system. Methodology
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $4.00 | +308.33% |
| Average target | $7.00 | +614.58% |
| High target | $10.00 | +920.82% |